Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.

Journal: Annals of medicine
Published Date:

Abstract

INTRODUCTION: Artificial intelligence (AI) is expected to impact all facets of inflammatory bowel disease (IBD) management, including disease assessment, treatment decisions, discovery and development of new biomarkers and therapeutics, as well as clinician-patient communication.

Authors

  • Philippe Pinton
    Clinical and Translational Sciences, Ferring Pharmaceuticals, Kastrup, Denmark.